Our Services
Medical Information
Helpful Resources
Published on: 9/16/2026
Yes, corticosteroids such as prednisone are a well-known cause of lymphopenia (low lymphocyte count), often within hours of a dose, by redistributing lymphocytes out of the bloodstream and triggering apoptosis of certain T cells. The drop is usually temporary and reverses after the steroid is tapered or stopped, though dose, duration, and your baseline immune health all influence how low the count goes and what it means for infection risk. Other causes, including infections, autoimmune disease, nutritional deficiencies, and blood disorders, can look identical on a lab report, so there are several important factors to consider before assuming steroids are the only explanation. See below to understand more about timing, typical numbers, and when a low lymphocyte count warrants further testing.
If you are trying to make sense of an abnormal lab result or new symptoms while on prednisone, a free, instant, online symptom check can help you organize what you are experiencing, surface possibilities worth discussing, and decide how soon to contact your doctor.
Last reviewed for medical accuracy: 09/15/2025
Can Steroids Like Prednisone Cause My Lymphocytes to Be Low?
Prednisone is a synthetic corticosteroid often prescribed for inflammation, autoimmune conditions and allergic reactions. While it can bring significant relief, it also affects your immune system. One common lab finding during prednisone therapy is “lymphocytes low” (lymphopenia). Below, we’ll explain why this happens, what it means for you, and when to seek medical advice.
What Are Lymphocytes?
Lymphocytes are a type of white blood cell crucial for fighting infections and orchestrating immune responses. They include:
When your blood test reports “lymphocytes low,” it means fewer lymphocytes than the standard reference range. Mild lymphopenia may cause no symptoms. But significant drops can increase infection risk.
How Prednisone Lowers Lymphocyte Counts
Prednisone suppresses the immune system in several ways, leading to “lymphocytes low”:
Redistribution
Apoptosis (programmed cell death)
Reduced production
Impaired survival
Who’s Most at Risk?
The likelihood and severity of “lymphocytes low” depend on:
Clinical Implications of Lymphopenia
A mild drop in lymphocytes often causes no obvious symptoms. However, more pronounced or prolonged lymphopenia can lead to:
Watch for warning signs such as:
Monitoring and Management
If you’re on prednisone, your doctor will likely schedule routine blood tests (CBC with differential) to track white blood cell counts. Here’s what you can do:
• Keep a record of your lab results. Note trends in lymphocyte counts.
• Report any new infections or unusual symptoms promptly.
• Avoid close contact with sick individuals and practice good hand hygiene.
• Discuss dose adjustments or temporary drug holidays if lymphopenia is severe.
• Ask about prophylactic treatments if you need long-term high-dose prednisone (e.g., antiviral or antifungal prevention).
Balancing Benefits and Risks
Prednisone often remains the best choice for controlling serious inflammation or autoimmune flares. The goal is to use the lowest effective dose for the shortest period possible. Your healthcare team may:
Lifestyle Tips to Support Your Immune System
While on prednisone, you can help your body cope by focusing on general health strategies:
When to Seek Further Evaluation
If you experience any of the following, speak to your doctor right away:
For non-urgent concerns—such as mild fatigue, occasional low-grade fevers, or new skin changes—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide if you need medical attention and what to ask your healthcare provider next.
Key Takeaways
Speak to a doctor if you experience warning signs of severe infection or any issue that feels urgent. Proper monitoring and open communication with your healthcare team will help you reap the benefits of prednisone while minimizing the impact of “lymphocytes low.”
(References)
* Shoenfeld Y, Gurewich Y, Gallant LA, Pinkhas J. Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am J Med. 1981 Nov;71(5):773-8. doi: 10.1016/0002-9343(81)90363-6. PMID: 7304648.
* Pouratian N, Gasco J, Sherman JH, Shaffrey ME, Schiff D. Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas. J Neurooncol. 2007 May;82(3):281-8. doi: 10.1007/s11060-006-9280-4. Epub 2006 Nov 3. PMID: 17082887.
* Li L, Hsu SH, Gu X, Jiang S, Shang L, Sun G, Sun L, Zhang L, Wang C, Ren Y, Wang J, Pan J, Liu J, Bin C. Aetiology and prognostic risk factors of mortality in patients with pneumonia receiving glucocorticoids alone or glucocorticoids and other immunosuppressants: a retrospective cohort study. BMJ Open. 2020 Oct 27;10(10):e037419. doi: 10.1136/bmjopen-2020-037419. Epub 2020 Oct 27. PMID: 33109645; PMCID: PMC7592294.
* Perret M, Bernard A, Rahmani A, Manckoundia P, Putot A. Acute Labyrinthitis Revealing COVID-19. Diagnostics (Basel). 2021 Mar 9;11(3). doi: 10.3390/diagnostics11030482. Epub 2021 Mar 9. PMID: 33803267; PMCID: PMC8002116.
* Hwang S, Tatsi C, Kuehn HS, Niemela JE, Stoddard J, Su Y, Lodish M, Uzel G, Spolski R, Leonard WJ, Holland SM, Fleisher TA, Stratakis CA, Rosenzweig SD. Cushing syndrome and glucocorticoids: T-cell lymphopenia, apoptosis, and rescue by IL-21. J Allergy Clin Immunol. 2022 Jan;149(1):302-314. doi: 10.1016/j.jaci.2021.05.031. Epub 2021 Jun 2. PMID: 34089750; PMCID: PMC8636539.
* Winzinger EP, Jandikova H, Haase M, Knauerhase A, Winzinger T, Schott M, Willenberg HS. DHEAS and Differential Blood Counts as Indirect Signs of Glucocorticoid Excess in Adrenal Non-Producing Adenomas. Horm Metab Res. 2021 Aug;53(8):512-519. doi: 10.1055/a-1539-6442. Epub 2021 Aug 12. PMID: 34384108.
* Berthelot A, Bequet C, Harlay V, Petrirena G, Campello C, Barrié M, Appay R, Chinot O, Tabouret E. Prognostic value of circulating lymphocyte subsets in primary central nervous system lymphoma. J Neurooncol. 2022 Aug;159(1):15-22. doi: 10.1007/s11060-022-04032-5. Epub 2022 Jun 28. PMID: 35763119.
* Herrera AF, Zain J, Savage KJ, Feldman T, Brammer JE, Chen L, Puverel S, Popplewell L, Budde LE, Mei M, Hosing C, Nair R, Leslie L, Daniels S, Peters L, Forman S, Rosen S, Kwak L, Iyer SP. Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study. Lancet Haematol. 2024 Sep;11(9):e671-e681. doi: 10.1016/S2352-3026(24)00171-6. Epub 2024 Jul 24. PMID: 39067464.
* Foss F, Kim YH, Scarisbrick J, Akilov O, Ristuccia R, Dwyer K, Wu W, Bagot M. Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab. J Dermatolog Treat. 2025 Dec;36(1):2438794. doi: 10.1080/09546634.2024.2438794. Epub 2025 Feb 2. PMID: 39894454.
* Campian JL, Grossman SA, Kask AS, Kosydar S, Strowd R, Piotrowski A, Tang J, Chheda MG, DiPersio JF, Schullery D, D'Amico L, Desideri S, Danda N, Ferrando-Martinez S, Lee BH, Fling SP, Ye X. Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma. Neurooncol Adv. 2025 Jan-Dec;7(1):vdaf117. doi: 10.1093/noajnl/vdaf117. Epub 2025 Jun 7. PMID: 40703805; PMCID: PMC12284640.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.